AAA iCarbonX ecosystem invests $400m in seven companies

iCarbonX ecosystem invests $400m in seven companies

China-based digital health technology developer iCarbonX has directed almost $400m in funding from its ecosystem to a total of seven members of its Digital Life Alliance initiative.

Founded in late 2015, iCarbonX is combining artificial intelligence with an individual’s biological, behavioural and psychological data to create what it calls an online ecosystem of digital life.

The company has raised a total of approximately $200m in funding from backers including internet group Tencent, genomic engineering technology provider Vcanbio, private equity fund Invus and investment banking firm China Bridge Capital.

The Digital Life Alliance aims to bring together companies that are developing biotech, sequencing, health networking and artificial intelligence technology in a bid to find meaningful signals about health, aging and disease.

US-based personalised health network PatientsLikeMe has secured $100m from iCarbonX and Invus through the initiative. It had previously raised more than $25m from Invus, Collaborative Seed and Growth Partners, CommerceNet and Omidyar Network since it was founded in 2004.

The other members of the program include US-based protein-measurement technology provider SomaLogic, which said in a separate statement it will receive an undisclosed amount of equity funding from iCarbonX.

SomaLogic had already raised about $108m in financing from pharmaceutical firm Novartis, clinical testing services provider Quest Diagnostics, financial services firm Societe Generale, ProQuest Investments, Stronghold Capital and Butcher Holdings.

US-based microbiome technology developer AOBiome is securing  $30m from the iCarbonX ecosystem, adding to about $4m in equity funding previously raised, according to regulatory filings.

Other Digital Life Alliance members include disease diagnostics platform developer HealthTell, microbial detection startup Galt (General Automation Lab Technologies), China-based recombinant enzyme developer Robustnique and Israel-based image analysis technology producer Imagu, which iCarbonX acquired in September 2016.

Leave a comment

Your email address will not be published. Required fields are marked *